Sanofi-Aventis to complete Zentiva acquisition

Sanofi-Aventis will hold a 94% stake in the Czech Republic's Zentiva when it completes its acquisition on March 11th. All the conditions put out by Sanofi-Aventis Europe, a subsidiary which is handling the deal, have been successfully fulfilled, it added.